Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Sami Corwin from William Blair maintained a Buy rating on Beam Therapeutics.
Beam’s newest liver-targeted genetic disease program, BEAM-304, leverages Beam’s proprietary and clinically validated base editing technology and lipid nanoparticle (LNP) delivery capabilities to ...
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate. The agreement, ...
Below are surveys that can be used to evaluate trainee progress and to gather feedback from trainees about the mentoring they have received and their satisfaction with their training program. The ...
Logic models are a visual representation of your program. They display the resources available for your program, the short and long-term goals for your trainees and the activities that you have ...
TIOBE Index for March 2026: Top 10 Most Popular Programming Languages Your email has been sent Python keeps the top spot as its rating dips again, C climbs further in second, and the bottom stays ...
For people with osteoarthritis (OA), exercise is good medicine. It eases joint pain, fights off fatigue, and helps you feel better overall. Want an easy way to get moving? Try walking. You can do it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results